NRx announced it will present evidence Wednesday that its drug aviptadil helps prevent cytokine storms in COVID patients.

An FDA advisory panel recommended against approval of roxadustat, FibroGen's drug for anemia stemming from chronic kidney disease.

Teleflex shares fell sharply, after the CMS proposed reimbursement rules that include a 20% cut in physician payments for UroLift.

PG&E intends to file for bankruptcy amid billions of dollars in lawsuits over its role in the California wildfires last year.

Jim Cramer explains what's behind these markets moves, both up and down. He thinks changes are being caused by short sellers whose bets have gone awry.

Here are Friday's top research calls, including upgrades for Cognizant, American International and Hershey, and a downgrade for Allstate.

Stocks fluctuate on Friday afternoon in choppy trading as banks beat a retreat after days of gains.

Stocks were mostly higher after U.S. jobs gains in November solidified the chances of an interest rate hike in December.

Stocks hold mixed on Friday after U.S. jobs gains in November solidify the chances of a December rate hike.

The takeover of the budget airline raises a key question for consumers.

Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.

Retailing giant Walmart wants to ensure its customers can get what they're looking for, however they want to buy it.